JPS6016933B2 - ２，６−ジメチル−３，５−ジメトキシカルボニル−４−（０−ジフルオロメトキシフエニル）−１，４−ジヒドロピリジン - Google Patents
２，６−ジメチル−３，５−ジメトキシカルボニル−４−（０−ジフルオロメトキシフエニル）−１，４−ジヒドロピリジンInfo
- Publication number
- JPS6016933B2 JPS6016933B2 JP54001047A JP104779A JPS6016933B2 JP S6016933 B2 JPS6016933 B2 JP S6016933B2 JP 54001047 A JP54001047 A JP 54001047A JP 104779 A JP104779 A JP 104779A JP S6016933 B2 JPS6016933 B2 JP S6016933B2
- Authority
- JP
- Japan
- Prior art keywords
- dihydropyridine
- dimethyl
- dimethoxycarbonyl
- difluoromethoxyphenyl
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- YNGDWRXWKFWCJY-UHFFFAOYSA-N 1,4-Dihydropyridine Chemical compound C1C=CNC=C1 YNGDWRXWKFWCJY-UHFFFAOYSA-N 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 description 26
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 230000001077 hypotensive effect Effects 0.000 description 5
- 230000004872 arterial blood pressure Effects 0.000 description 4
- ACZJZGLXRPZSLI-UHFFFAOYSA-N diethyl 2,6-dimethyl-4-[2-(trifluoromethyl)phenyl]-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1C1=CC=CC=C1C(F)(F)F ACZJZGLXRPZSLI-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 241000700159 Rattus Species 0.000 description 3
- 230000003276 anti-hypertensive effect Effects 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- AZVFIZVKGSPGPK-UHFFFAOYSA-N ryodipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1OC(F)F AZVFIZVKGSPGPK-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- WRQNANDWMGAFTP-UHFFFAOYSA-N Methylacetoacetic acid Chemical compound COC(=O)CC(C)=O WRQNANDWMGAFTP-UHFFFAOYSA-N 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 231100000053 low toxicity Toxicity 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- XQYZDYMELSJDRZ-UHFFFAOYSA-N papaverine Chemical compound C1=C(OC)C(OC)=CC=C1CC1=NC=CC2=CC(OC)=C(OC)C=C12 XQYZDYMELSJDRZ-UHFFFAOYSA-N 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- QPBNHDFPMRENBC-UHFFFAOYSA-N 2-(difluoromethoxy)benzaldehyde Chemical compound FC(F)OC1=CC=CC=C1C=O QPBNHDFPMRENBC-UHFFFAOYSA-N 0.000 description 1
- 229930008281 A03AD01 - Papaverine Natural products 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 102000052591 Anaphase-Promoting Complex-Cyclosome Apc6 Subunit Human genes 0.000 description 1
- 108700004603 Anaphase-Promoting Complex-Cyclosome Apc6 Subunit Proteins 0.000 description 1
- 101100005736 Arabidopsis thaliana APC6 gene Proteins 0.000 description 1
- 101150017278 CDC16 gene Proteins 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 101100327311 Dictyostelium discoideum anapc6 gene Proteins 0.000 description 1
- JNCMHMUGTWEVOZ-UHFFFAOYSA-N F[CH]F Chemical compound F[CH]F JNCMHMUGTWEVOZ-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 108010081348 HRT1 protein Hairy Proteins 0.000 description 1
- 102100021881 Hairy/enhancer-of-split related with YRPW motif protein 1 Human genes 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- -1 adrenaline Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 229960001789 papaverine Drugs 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 231100000916 relative toxicity Toxicity 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU782569286A SU706410A1 (ru) | 1978-01-11 | 1978-01-11 | 2,6-Диметил-3,5-дикарбметокси-4(0-дифторметоксифенил)-1,4-дигидропиридин,обладающий выраженной гипотензивной активностью и оказывающий действие на функции вегетативной нервной системы |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS54122280A JPS54122280A (en) | 1979-09-21 |
| JPS6016933B2 true JPS6016933B2 (ja) | 1985-04-30 |
Family
ID=20744355
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP54001047A Expired JPS6016933B2 (ja) | 1978-01-11 | 1979-01-11 | ２，６−ジメチル−３，５−ジメトキシカルボニル−４−（０−ジフルオロメトキシフエニル）−１，４−ジヒドロピリジン |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4219653A (en]) |
| JP (1) | JPS6016933B2 (en]) |
| CA (1) | CA1117124A (en]) |
| DE (1) | DE2900537A1 (en]) |
| FR (1) | FR2414501A1 (en]) |
| GB (1) | GB2013186B (en]) |
| SU (1) | SU706410A1 (en]) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4435574A (en) * | 1981-07-20 | 1984-03-06 | Kastron Valeria V | 2,6-Dimethyl-3,5-dicarbomethoxy-4-(ortho-di-fluoromethylthiophenyl)-1,4-dihydropyridine |
| DE3207982A1 (de) * | 1982-03-05 | 1983-09-08 | Bayer Ag, 5090 Leverkusen | Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihrer verwendung in arzneimitteln |
| JPS58213712A (ja) * | 1982-06-07 | 1983-12-12 | Nikken Kagaku Kk | Ｐｐ−１４６６含有持続性製剤 |
| JPS59129279A (ja) * | 1983-01-12 | 1984-07-25 | Sekisui Chem Co Ltd | ウレタン系粘着剤層の形成方法 |
| IE57810B1 (en) * | 1984-03-27 | 1993-04-21 | Delagrange Lab | 1,4-dihydropyridine derivatives,their preparation and their use |
| EP0205511A1 (de) * | 1984-12-21 | 1986-12-30 | Byk Gulden Lomberg Chemische Fabrik GmbH | Neue piperazinderivate |
| GB2180532B (en) * | 1985-09-17 | 1989-08-23 | Inst Organicheskogo Sinteza Ak | Alkoxy-and phenoxy-alkyl-esters of 2,6-dimethyl-4-(2-difluoromethoxyphenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid |
| WO1988003529A1 (en) * | 1986-11-10 | 1988-05-19 | Institut Organicheskogo Sinteza Akademii Nauk Latv | 2-methylmercapto-3-cyano-4-(o-difluoromethoxyphenyl)-6-phenyl-1,4-dihydropyridine |
| GB2221677A (en) * | 1988-08-08 | 1990-02-14 | Inst Organicheskogo Sinteza Ak | 2,6-dimethyl-4-/2'-difluoromethoxyphenyl/-1,4-dihydropyridine-3,5-dicarboxylates |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3441648A (en) * | 1967-02-07 | 1969-04-29 | Smithkline Corp | Compositions and methods for lowering blood pressure with 1,4-dihydropyridines |
| DE1670827C3 (de) * | 1967-03-20 | 1974-10-24 | Bayer Ag, 5090 Leverkusen | 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin |
| GB1430961A (en) * | 1972-01-22 | 1976-04-07 | Yamanouchi Pharma Co Ltd | 1-substituted-1,4-dihyddrypyridine derivatives |
| US4021434A (en) * | 1972-01-22 | 1977-05-03 | Yamanouchi Pharmaceutical Co., Ltd. | Sodium β-[2,6-dimethyl-3,5-bis(ethoxycarbonyl)-4-(3-nitrophenyl)-1,4-dihydropyridine-1-yl]ethyl sulfate |
-
1978
- 1978-01-11 SU SU782569286A patent/SU706410A1/ru active
-
1979
- 1979-01-05 US US06/001,148 patent/US4219653A/en not_active Expired - Lifetime
- 1979-01-08 DE DE19792900537 patent/DE2900537A1/de active Granted
- 1979-01-09 GB GB7900717A patent/GB2013186B/en not_active Expired
- 1979-01-10 FR FR7900537A patent/FR2414501A1/fr active Granted
- 1979-01-10 CA CA000319424A patent/CA1117124A/en not_active Expired
- 1979-01-11 JP JP54001047A patent/JPS6016933B2/ja not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| FR2414501A1 (fr) | 1979-08-10 |
| FR2414501B1 (en]) | 1983-11-18 |
| US4219653A (en) | 1980-08-26 |
| GB2013186B (en) | 1982-07-14 |
| JPS54122280A (en) | 1979-09-21 |
| GB2013186A (en) | 1979-08-08 |
| CA1117124A (en) | 1982-01-26 |
| SU706410A1 (ru) | 1979-12-30 |
| DE2900537A1 (de) | 1979-07-12 |
| DE2900537C2 (en]) | 1988-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK645689A (da) | Nye piperazinderivater | |
| EP0176956B1 (de) | Neue Diarylverbindungen | |
| DE2462086A1 (de) | 4-aryl-1,4-dihydropyridine, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel | |
| JPS6016933B2 (ja) | ２，６−ジメチル−３，５−ジメトキシカルボニル−４−（０−ジフルオロメトキシフエニル）−１，４−ジヒドロピリジン | |
| WO2002034754A3 (en) | Benzoxazinone derivatives, their preparation and use | |
| DE69131359D1 (de) | Kondensierte Thiazolverbindungen, ihre Darstellung und ihre Anwendung | |
| US3696112A (en) | Sulphur-containing 1,4-dihydropyridine derivatives | |
| GB2158065A (en) | Dihydropyridines | |
| ES8700856A1 (es) | Un procedimiento para la preparacion de compuestos de 1, 4-dihidropiridina | |
| IE852285L (en) | Piperazinylindanes | |
| JPS63290868A (ja) | ジケトピペラジン誘導体およびその塩類 | |
| PT1080081E (pt) | Derivados do benzofuraxano e a sua utilizacao no tratamento da angina de peito | |
| JPS6013789A (ja) | １，４−ジヒドロピリジン誘導体、その製造および医薬 | |
| FI60704C (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbar 2,6-dimetyl-3-metoxikarbonyl-4-(2'-nitrofenyl)-1,4-dihydropyridin-5-karboxylsyraisobutylester | |
| JPS62281860A (ja) | アルキレンアミノアルキレン ヘテロ原子基を有するジヒドロ−３，５−ジカルボキシレ−ト | |
| US4435574A (en) | 2,6-Dimethyl-3,5-dicarbomethoxy-4-(ortho-di-fluoromethylthiophenyl)-1,4-dihydropyridine | |
| DE2531829A1 (de) | N-(3,4,5-trimethoxycinnamoyl)-n'- (2'-pyrrolidinon-1'-carbonylmethyl) -piperazin, verfahren zu dessen herstellung und diese verbindung enthaltende arzneipraeparate | |
| CH626069A5 (en) | Process for the preparation of substituted imidazoles | |
| US3515787A (en) | Compositions and methods for producing a muscle relaxing effect in an animal with 2,3 - substituted - 6 - amino-4-quinazolones | |
| US3535321A (en) | 2-carbalkoxyaminodihydroquinazolines | |
| US3420839A (en) | Aminomethyl pyrazolone derivatives of nicotinamide | |
| JPS59170094A (ja) | 置換された４，１０−ジヒドロ−１０−オキソチエノ−ベンズオキセピン類およびその製法 | |
| JPS6026785B2 (ja) | 新規イリキノリン誘導体の製法 | |
| JPS6022714B2 (ja) | キナゾリン誘導体及びその製造法 | |
| DE1934966A1 (de) | Neue 2-Methyl-3-benzyl-3H(4,5-b)-imidazopyridine und Verfahren zu ihrer Herstellung |